Monica Kong-Beltran, Jennifer Stamos, Dineli Wickramasinghe 

Slides:



Advertisements
Similar presentations
Volume 14, Issue 6, Pages (June 2001)
Advertisements

Constitutive NF-κB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity  Honglin Zhou, Ming-Qing.
Volume 18, Issue 6, Pages (December 2010)
Volume 6, Issue 5, Pages (November 2004)
Functional analysis of the cytoplasmic domain of the integrin α1 subunit in endothelial cells by Tristin D. Abair, Nada Bulus, Corina Borza, Munirathinam.
Volume 142, Issue 7, Pages e6 (June 2012)
Volume 11, Issue 4, Pages (April 2003)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 36, Issue 5, Pages (December 2009)
Volume 8, Issue 5, Pages (November 2001)
Volume 5, Issue 4, Pages (April 2004)
Volume 33, Issue 2, Pages (January 2009)
Volume 15, Issue 19, Pages (October 2005)
Volume 28, Issue 3, Pages (September 2015)
The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein  Ben N.G. Giepmans, Wouter H. Moolenaar  Current.
The C-terminus of Hsp70-Interacting Protein Promotes Met Receptor Degradation  Kang Won Jang, PhD, Jeong Eun Lee, MD, Sun Young Kim, MD, Min-Woong Kang,
Volume 22, Issue 5, Pages (May 2012)
Volume 18, Issue 6, Pages (December 2010)
ASK1 Is Essential for JNK/SAPK Activation by TRAF2
Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis  Fumihiko Hayakawa, Martin L Privalsky 
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Volume 25, Issue 9, Pages (September 2017)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Ras Induces Mediator Complex Exchange on C/EBPβ
Volume 23, Issue 6, Pages (June 2013)
Robert L.S Perry, Maura H Parker, Michael A Rudnicki  Molecular Cell 
Volume 8, Issue 5, Pages (November 2001)
Volume 29, Issue 3, Pages (February 2008)
Arachidonic acid induces ERK activation via Src SH2 domain association with the epidermal growth factor receptor  L.D. Alexander, Y. Ding, S. Alagarsamy,
Calnexin Controls the STAT3-Mediated Transcriptional Response to EGF
Xiaolong Wei, Hai Xu, Donald Kufe  Cancer Cell 
Volume 18, Issue 5, Pages (January 2017)
Volume 4, Issue 2, Pages (February 1996)
Volume 10, Issue 6, Pages (December 2006)
Volume 12, Issue 4, Pages (October 2003)
Yang Shen, Monica Naujokas, Morag Park, Keith Ireton  Cell 
Role of the regulatory domain of the EGF-receptor cytoplasmic tail in selective binding of the clathrin-associated complex AP-2  Werner Boll, Andreas.
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Volume 7, Issue 4, Pages (April 2001)
C-Jun Downregulation by HDAC3-Dependent Transcriptional Repression Promotes Osmotic Stress-Induced Cell Apoptosis  Yan Xia, Ji Wang, Ta-Jen Liu, W.K.
Volume 25, Issue 5, Pages (November 2006)
Volume 10, Issue 1, Pages (July 2002)
Paxillin Serves as an ERK-Regulated Scaffold for Coordinating FAK and Rac Activation in Epithelial Morphogenesis  Shuta Ishibe, Dominique Joly, Zhen-Xiang.
Protein Kinase C-βII Represses Hepatocyte Growth Factor-Induced Invasion by Preventing the Association of Adapter Protein Gab1 and Phosphatidylinositol.
Lysine 63 Polyubiquitination of the Nerve Growth Factor Receptor TrkA Directs Internalization and Signaling  Thangiah Geetha, Jianxiong Jiang, Marie W.
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
Volume 61, Issue 6, Pages (June 2002)
ER Stress Regulation of ATF6 Localization by Dissociation of BiP/GRP78 Binding and Unmasking of Golgi Localization Signals  Jingshi Shen, Xi Chen, Linda.
Volume 103, Issue 6, Pages (December 2000)
Volume 20, Issue 4, Pages (November 2005)
Amphiregulin Exosomes Increase Cancer Cell Invasion
Volume 96, Issue 5, Pages (March 1999)
Volume 20, Issue 3, Pages (July 2017)
Ruth Halaban, Elaine Cheng  Journal of Investigative Dermatology 
Volume 96, Issue 6, Pages (March 1999)
Volume 50, Issue 6, Pages (June 2013)
Tzu-Ching Meng, Toshiyuki Fukada, Nicholas K Tonks  Molecular Cell 
Kimita Suyama, Irina Shapiro, Mitchell Guttman, Rachel B. Hazan 
Mst1 Is an Interacting Protein that Mediates PHLPPs' Induced Apoptosis
Silva H Hanissian, Raif S Geha  Immunity 
Volume 57, Issue 2, Pages (October 2000)
Volume 125, Issue 4, Pages (May 2006)
Yvonne Ng, Georg Ramm, Jamie A. Lopez, David E. James  Cell Metabolism 
Livio Trusolino, Andrea Bertotti, Paolo M Comoglio  Cell 
RhoA GTPase Regulates B Cell Receptor Signaling
Phosphorylation and Functional Inactivation of TSC2 by Erk
Constitutive NF-κB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity  Honglin Zhou, Ming-Qing.
Volume 36, Issue 4, Pages (November 2009)
c-IAP1 Cooperates with Myc by Acting as a Ubiquitin Ligase for Mad1
Volume 31, Issue 5, Pages (September 2008)
Presentation transcript:

The Sema domain of Met is necessary for receptor dimerization and activation  Monica Kong-Beltran, Jennifer Stamos, Dineli Wickramasinghe  Cancer Cell  Volume 6, Issue 1, Pages 75-84 (July 2004) DOI: 10.1016/j.ccr.2004.06.013 Copyright © 2004 Cell Press Terms and Conditions

Figure 1 Schematic representation of Met deletion mutants Subdomain deletions of the Met extracellular domain were made from the N terminus and tagged after the TM region with V5/His. The Met signal peptide (S.P.) sequence was appended to the N terminus of each mutant. Abbreviations: Sema, semaphorin; PSI, plexin, semaphorin, integrin; IPT, immunoglobulin-like regions in plexins and transcription factors; and TM, transmembrane. The arrow on the Sema region points to the Met proteolytic site. Cancer Cell 2004 6, 75-84DOI: (10.1016/j.ccr.2004.06.013) Copyright © 2004 Cell Press Terms and Conditions

Figure 2 The Sema domain is necessary for crosslinking Met A: The Met deletion mutants were transfected into 293 cells and exposed to increasing concentrations of sulfo-EGS. 10 μg of lysates were analyzed by 4%–12% SDS-PAGE and immunoblotted with V5 antibody. EC-M and EC-D represent EC-WT monomer and dimer, respectively. The asterisk indicates the presence of unprocessed EC-WT. B: EC-WT-Flag and EC-WT-V5/His were cotransfected in 293 cells, subjected to increasing concentrations of sulfo-EGS, lysed, immunoprecipitated with either V5 or Flag antibodies, and analyzed by 8% SDS-PAGE. The immunoprecipitated samples were blotted with either Flag or V5 antibodies. Cancer Cell 2004 6, 75-84DOI: (10.1016/j.ccr.2004.06.013) Copyright © 2004 Cell Press Terms and Conditions

Figure 3 HGF, scHGF (R494E), and anti-Met 5D5 antibody bind the Sema domain of Met A: 293 cells were transfected with the indicated Met-V5/His tagged construct, immunoprecipitated with V5 antibody, analyzed by 4%–12% SDS-PAGE, and immunoblotted with His antibody. B: Top: The immunoprecipitates from A were incubated with 5 μg HGF. The samples were analyzed by 4%–12% SDS-PAGE and immunoblotted with HGF antibody that recognizes the α chain. 10 ng of input HGF served as a positive control. Bottom: Immunoprecipitations and immunoblotting were performed as in the top panel using scHGF (R494E). As a positive control, 15 ng scHGF (R494E) was analyzed with the samples. C: 293 cells were transfected with the indicated constructs and analyzed by 4%–12% SDS-PAGE. Lysates were immunoprecipitated with anti-Met 5D5 antibody and immunoblotted with His antibody (top) and reprobed with Met C-12 antibody (bottom). D: Endogenous Met is crosslinked in tumor cells. Increasing concentrations of sulfo-EGS were added to 293, H441, MDA-MB-435, and A549 cells that had been serum starved. A549 cells were also incubated with 10 μg/ml HGF prior to crosslinking. Lysates were immunoblotted with Met C-12 antibody. As a control, full-length Met-V5/His was transfected into 293 cells, crosslinked, and immunoblotted with V5 antibody. Cancer Cell 2004 6, 75-84DOI: (10.1016/j.ccr.2004.06.013) Copyright © 2004 Cell Press Terms and Conditions

Figure 4 Met signal transduction is inhibited by rSema and anti-Met 5D5-Fab A: A549 cells were kept serum-free and treated with 0, 5, 10, 50, or 100 μg/ml of rSema with 10 ng/ml HGF for 10 min for phospho-Met and phospho-MAPK analysis. Lysates were immunoprecipitated with Met C-12 antibody and immunoblotted with phospho-tyrosine antibodies to detect phosphorylated Met followed by immunoblotting with Met antibody. H441 and MDA-MB-435 cells were treated with 0, 5, 10, or 100 μg/ml rSema plus 5 or 10 ng/ml HGF, respectively, for 5 min. Proteins were detected with phospho-MAPK and reprobed with MAPK antibodies. B: The data in A were quantified using NIH Image software and are represented as bar graphs in the left panels comparing the ratio of phosphorylated to unphosphorylated proteins between each sample. The right panels represent data from another experiment. C: A549, H441, and MDA-MB-435 cells were kept serum-free and treated with 10 μg/ml rSema or anti-Met 5D5-Fab. The samples were immunoblotted with phospho-tyrosine, Met, phospho-MAPK, or MAPK antibodies. D: The data in C were quantified and presented as in B. Cancer Cell 2004 6, 75-84DOI: (10.1016/j.ccr.2004.06.013) Copyright © 2004 Cell Press Terms and Conditions

Figure 5 The extracellular domain of Met attenuates Met signal transduction A: A549 cells were transfected with the indicated constructs. The expression of the Met mutants was detected by immunoblotting with V5 antibody. B: Left: Lysates from A were immunoprecipitated with Met C-12 antibody and immunoblotted with phospho-tyrosine antibody. The membrane was reprobed with Met antibody. Right: Lysates were immunoblotted with phospho-MAPK and then reprobed with MAPK. C: The data in B were quantified using NIH Image software and are represented as bar graphs in the left panels comparing the ratio of phosphorylated to unphosphorylated proteins for each sample. The right panels represent data from another experiment. Cancer Cell 2004 6, 75-84DOI: (10.1016/j.ccr.2004.06.013) Copyright © 2004 Cell Press Terms and Conditions

Figure 6 rSema and anti-Met 5D5-Fab inhibit cell motility A: H441 cells were scraped on Day 0 and treated with increasing concentrations of rSema plus HGF in serum-free media. The scrapes were photographed on Day 0 and Day 1. A representative data set of three independent experiments is shown. B: H441 cells were scraped and treated with mock, rSema, or anti-Met 5D5-Fab in serum-free media over the course of 2 days. Photographs were taken on Day 0 and Day 2. Four independent experiments were carried out and a representative data set is shown. Cancer Cell 2004 6, 75-84DOI: (10.1016/j.ccr.2004.06.013) Copyright © 2004 Cell Press Terms and Conditions

Figure 7 Cell migration is inhibited by rSema and anti-Met 5D5-Fab A: MDA-MB-435 cells were pre-incubated with increasing concentrations of rSema and seeded into the upper chambers of a transwell plate in serum-free media. The lower chambers contained 100 ng/ml HGF with the exception of mock-treated wells. B: Cells were pre-incubated with 10 μg/ml anti-Met 5D5-Fab or increasing concentrations of rSema and then seeded into the upper chamber of each transwell in serum-free media. The lower chamber contained serum-free media. The data are representative of three independent experiments performed in duplicate. The migrating cells were stained with crystal violet and the absorbance of eluted cells was measured at 560 nm. Cancer Cell 2004 6, 75-84DOI: (10.1016/j.ccr.2004.06.013) Copyright © 2004 Cell Press Terms and Conditions